Tag:
alcohol dependence
Latest Headlines
Latest Headlines
PhIII placebo response complicates Lundbeck's case for anti-drinking drug
Lundbeck has taken the wraps off its Phase III data for the alcohol dependence drug nalmefene.
Lundbeck files app for alcohol dependence drug
Lundbeck has filed for European approval of Selincro, a new treatment for alcohol dependence. The Dutch company obtained the treatment in a 96 million euro licensing deal with Biotie . New late-stage
Lundbeck nails PhIII for drug to curb alcohol dependence
With high hopes to change the way alcohol dependence is treated, Copenhagen-based drug company Lundbeck has shown that its experimental pill nalmefene has passed a final Phase III trial in route to
